301096.SZ · 百诚医药
China A-shares · RS rating 21 · As of 2026-10-14
| Price | 41.59 CNY |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 21 / 54 / 25 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 18 / 3 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -10.3% |
| Distance from 52-week high | +39.7% |
| Market cap (USD) | $745.7M |